Michael Richman - President & CEO, Director at NextCure, Inc.

Issuer-level insider activity

Role
President & CEO, Director
Issuer symbol
NXTC on Nasdaq
Identity 1 fact
Entity type
Individual
SEC evidence 1 fact
Source evidence
Open source filing history

No buys or sells have been reported by Michael Richman since 01 Jun 2025

Reported holdings for Michael Richman in NextCure, Inc.

Form 4 holding President & CEO, Director

NextCure, Inc.

Security class
Employee Stock Option (Right to Buy)
Shares / value
38,190
Estimated value
Report date
30 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Michael Richman in NextCure, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .